echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Sihuan Biotechnology received a civil complaint involving three securities misrepresentation liability disputes

    Sihuan Biotechnology received a civil complaint involving three securities misrepresentation liability disputes

    • Last Update: 2021-04-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On March 20, Sihuan Biological issued an announcement stating that the company received a civil complaint and response from the Nanjing Intermediate People’s Court (2021) Su01 Minchu No.


    On April 27, 2020, the defendants Sihuan Biological and Lu Keping were imposed an administrative punishment and market ban by the China Securities Regulatory Commission for false statements.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.